Dissecting the role of CD4+ TFH-like cells as a therapeutic target and biomarker of immunotherapy activity Grant uri icon

Overview

date/time interval

  • June 15, 2020 - January 1, 2022

sponsor award ID

  • SRA 203365-01

Affiliation